Justus Cohen

Dr. Justus Cohen

orcid

Research Focus & Metrics

Academic Career Length

47Years (1980-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 July 2015 in Scientific Reports
Verified
Journal Article
Open access
PDF file
JHJianfeng Han
Jianfeng Han
JCJianhong Chu
Jianhong Chu
WCWing Keung Chan
Wing Keung Chan
JZJianying Zhang
Jianying Zhang
YWYouwei Wang
Youwei Wang
JYJianhua Yu
Jianhua Yu
Glioblastoma (GB) remains the most aggressive primary brain malignancy. Adoptive transfer of chimeric antigen receptor (CAR)-modified immune cells has emerged as a promising anti-cancer approach, yet the potential utility of CAR-engineered natural killer (NK) cells to treat GB has not been explored. Tumors from approximately 50% of GB patients express wild-type EGFR (wtEGFR) and in fewer cases express both wtEGFR and the mutant form EGFRvIII; however, previously reported CAR T cell studies only focus on targeting EGFRvIII. Here we explore whether both wtEGFR and EGFRvIII can be effectively targeted by CAR-redirected NK cells to treat GB. We transduced human NK cell lines NK-92 and NKL and primary NK cells with a lentiviral construct harboring a second generation CAR targeting both wtEGFR and EGFRvIII and evaluated the anti-GB efficacy of EGFR-CAR-modified NK cells. EGFR-CAR-engineered NK cells displayed enhanced cytolytic capability and IFN-γ production when co-cultured with GB cells or patient-derived GB stem cells in an EGFR-dependent manner. In two orthotopic GB xenograft mouse models, intracranial administration of NK-92-EGFR-CAR cells resulted in efficient suppression of tumor growth and significantly prolonged the tumor-bearing mice survival. These findings support intracranial administration of NK-92-EGFR-CAR cells represents a promising clinical strategy to treat GB.

1 July 1981 in Nature
Verified
Journal Article
Closed access
DGDavid Givol
David Givol
RZRina Zakut
Rina Zakut
KEKim Effron
Kim Effron
GRGideon Rechavi
Gideon Rechavi
DRDaniela Ram
Daniela Ram
JCJustus Cohen
Justus Cohen

1 December 1983 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
ECE Canaani
E Canaani
ODO Dreazen
O Dreazen
AKA Klar
A Klar
GRG Rechavi
G Rechavi
DRD Ram
D Ram
DGD Givol
D Givol
The activation of the cellular oncogene c-mos in mouse plasmacytoma XRPC24 was found to result from the insertion of a 4.7-kilobase-pair cellular DNA element, within the c-mos coding region. The element terminates on both sides with a direct repeat of around 335 nucleotides. The repeat as well as internal sequences of the element show strong homology to endogenous intracisternal A-particle (IAP) genes. The IAP genome integrated within c-mos in a head-to-head (5' to 5') configuration. This juxtapositioned the IAP 5' long terminal repeat next to the bulk of the oncogene's coding region and shifted c-mos 5' coding and flanking sequences to a position further upstream. The significance of several aspects of this activation and transposition event is discussed.

1 July 1988 in Nature
Verified
Journal Article
Closed access
JCJustus Cohen
Justus Cohen
ALArthur D. Levinson
Arthur D. Levinson

1 July 1982 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
GRG Rechavi
G Rechavi
BBB Bienz
B Bienz
DRD Ram
D Ram
YBY Ben-Neriah
Y Ben-Neriah
JCJustus Cohen
Justus Cohen
DGD Givol
D Givol
The organization and evolution of Ig variable region genes was studied by comparing human and mouse heavy chain variable region (VH) genes. A VH gene subgroup constitutes a physically linked multigene family separated from another VH subgroup. The VHIII gene subgroup was mapped to be 3'' to the VHII gene subgroup based on deletion of VH genes after V-D-J rearrangement. The human VHIII gene subgroup underwent a significant gene expansion as compared to the mouse VHIII subgroup. Human VHIII genes apparently correspond to only a small subset of mouse VHIII genes. Human VHIII genes contain a shorter intron and are 2 codons shorter than most BALB/c mouse VHIII genes. The nature of nucleotide substitutions between VH genes within a species (human) is similar to that between genes of different species (human/mouse). Both contain approximately 50% silent substitutions.

1 February 1985 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
NKN Katzir
N Katzir
GRG Rechavi
G Rechavi
JCJustus Cohen
Justus Cohen
TUT Unger
T Unger
FSF Simoni
F Simoni
DGD Givol
D Givol
We examined by Southern blotting the state of the cellular oncogene c-myc in the dog transmissible venereal tumor. The tumor DNA contains a 16.8-kilobase pair (kbp) rearranged c-myc fragment in addition to the normal 15-kbp and 7.5-kbp fragments. We compared the structure of the cloned rearranged c-myc (re-myc) with that of a cloned normal c-myc and found that the rearrangement was due to the insertion of a 1.8-kbp DNA upstream to the first exon of c-myc. The inserted DNA is flanked by 10-base-pair direct repeats and contains a dA-rich tail, suggesting its origin from mRNA. Partial sequence of the inserted element showed 62% homology with the primate interdispersed Kpn I repetitive element. These results provide an example for the behavior of repetitive DNA sequences like the Kpn I family, as movable elements that can transpose nearby to oncogenes or other structural genes and perhaps affect their activity.